Wound Infection: Clinical Trials

7 trials for Wound Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Terminated 7
Phase 21Terminated 1

Follow Wound Infection: new trials by email Literature Review of Wound Infection trials Research Report on Wound Infection

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery
D-PLEX, Standard of Care - Surgical Site Infection, Sternal Infection
Phase 3TerminatedPolyPid Ltd.22019-12-172026-06-30
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
Delafloxacin, Vancomycin, Linezolid - Surgical Site Infection
Phase 3TerminatedMenarini Group2682019-09-252022-02-02
Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery
Sennosides colonic preparation, Oral Gentamycin, Oral Ornidazole - Colon Cancer
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris1932018-08-082022-05-17
Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.
Ceftaroline fosamil, Vancomycin, Aztreonam - Complicated Skin and Soft Tissue Infection
Phase 3TerminatedPfizer42014-06-012017-09-06
A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
povidone-iodine solution, chlorhexidine gluconate - Wound Infection
Phase 3TerminatedMemorial University of Newfoundland2682007-12-012012-11-09
A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery
Betadine - Varicose Veins, Wound Infection
Phase 3TerminatedRoyal Hobart Hospital602004-06-012017-04-12
Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks
Sulfamylon 5% and Silver Nitrate Soaks - Burn
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston981995-07-012023-06-22

Narrower conditions

Surgical Wound Infection (3)  ·  Infections (2)  ·  Bacterial Infections (1)  ·  Burns (1)  ·  Cellulitis (1)  ·  Colonic Neoplasms (1)  ·  Erythema (1)  ·  Fever (1)  ·  Leukocytosis (1)  ·  Recurrence (1)  ·  Sepsis (1)  ·  Soft Tissue Infections (1)  ·  Vaginal Discharge (1)  ·  Varicose Veins (1)

Broader conditions

Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Infections (5)  ·  Postoperative Complications (3)  ·  Inflammation (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Bacterial Infections and Mycoses (1)  ·  Body Temperature Changes (1)  ·  Cardiovascular Diseases (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Connective Tissue Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)

Interventions

Povidone-Iodine (2)  ·  Vancomycin (2)  ·  Aztreonam (1)  ·  Ceftaroline (1)  ·  Chlorhexidine (1)  ·  Gentamicins (1)  ·  Linezolid (1)  ·  Mafenide (1)  ·  Ornidazole (1)  ·  Piperacillin, Tazobactam Drug Combination (1)  ·  Povidone (1)  ·  Silver Nitrate (1)  ·  Standard of Care (1)  ·  Tigecycline (1)  ·  chlorhexidine gluconate (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Memorial University of Newfoundland (1)  ·  Menarini Group (1)  ·  Pfizer (1)  ·  PolyPid Ltd. (1)  ·  Royal Hobart Hospital (1)  ·  The University of Texas Medical Branch, Galveston (1)

Countries

Israel (2)  ·  Italy (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  Croatia (1)  ·  France (1)  ·  Greece (1)  ·  Poland (1)  ·  Romania (1)  ·  South Africa (1)

Top investigators

David Melnick, MSD (1)  ·  David N Herndon, MD (1)  ·  Hartzell V. Schaff, M.D. (1)  ·  Paula Mallaley, MD (1)  ·  Stefano Margaritora (1)  ·  Stuart Walker, MBBS (1)

Results publications

PMID 27585969, PMID 40908975

NIH funding

2018 (1)